Issued Patents 2021
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11207392 | Coordinated multi-prong cancer therapy | Patrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Hans G. Klingemann, Barry J. Simon | 2021-12-28 |
| 11207350 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Tien Lee, Hans G. Klingemann, Barry J. Simon | 2021-12-28 |
| 11129850 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | Hans G. Klingemann, Nathan T. Schomer | 2021-09-28 |
| 11077143 | Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cells | Hans G. Klingemann, Abhijit Dandapat | 2021-08-03 |
| 11071774 | Nant cancer vaccine | Patrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Hans G. Klingemann | 2021-07-27 |
| 11058723 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | Hans G. Klingemann, Nathan T. Schomer | 2021-07-13 |
| 11000550 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Tien Lee, Hans G. Klingemann, Barry J. Simon | 2021-05-11 |
| 10960024 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | Hans G. Klingemann, John H. Lee, Nathan T. Schomer | 2021-03-30 |